Pharmatek
Pharmatek, officially known as Pharmatek Laboratories, Inc., is a leading contract development and manufacturing organisation (CDMO) headquartered in the United States. Established in 1999, the company has made significant strides in the pharmaceutical industry, specialising in formulation development, analytical services, and clinical manufacturing. With a strong presence in key operational regions across North America, Pharmatek is renowned for its innovative approach to drug development. The company offers a unique blend of services, including solid dosage forms and parenteral formulations, tailored to meet the specific needs of its clients. Pharmatek's commitment to quality and efficiency has positioned it as a trusted partner for pharmaceutical companies, contributing to its notable achievements in the market. With a focus on advancing drug delivery technologies, Pharmatek continues to play a pivotal role in the evolution of the pharmaceutical landscape.
DitchCarbon Score
How does Pharmatek's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmatek's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmatek's reported carbon emissions
Pharmatek, headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Pharmatek may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the industry increasingly prioritises sustainability, it is essential for companies like Pharmatek to establish clear emissions reduction strategies and publicly commit to measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmatek is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
